Hawkins JB, Jones MT, Plassmann PE, Thorley-Lawson DA. 2011. Chemotaxis in densely populated tissue determines germinal center anatomy and cell motility: a new paradigm for the development of complex tissues. PLoS One. 6: e27650. 
Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA. 2011. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog. 8: e1002193. 
Clute SC, Naumov YN, Watkin LB, Aslan N, Sullivan JL, Thorley-Lawson DA, Luzuriaga K, Welsh RM, Puzone R, Celada F, Selin LK. 2010. Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes. J Immunol. 185: 6753-6764.
Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, Würdinger T, Middeldorp JM. 2010. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107: 6328-6333.
Roughan JE, Torgbor C, Thorley-Lawson DA. 2010. Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol. 84: 1158-1168.
Hadinoto V, Shapiro M, Sun CC, Thorley-Lawson DA. 2009. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 5: e1000496.
Roughan JE, Thorley-Lawson DA. 2009. The intersection of Epstein-Barr virus with the germinal center. J Virol 83: 3968-3976.
Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA. 2009. Comprehensive profiling of EBV microRNAs in nasopharyngeal carcinoma. J Virol 83: 2357-2367.
Thorley-Lawson DA, Allday MJ. 2008. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 6: 913-624.
Shapiro M, Duca KA, Lee K, Delgado-Eckert E, Hawkins J, Jarrah AS, Laubenbacher R, Polys NF, Hadinoto V, Thorley-Lawson DA. 2008. A virtual look at Epstein-Barr virus infection: simulation mechanism. J Theor Biol 252: 633-648.
Thorley-Lawson DA, Duca KA, Shapiro M. 2008. Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual reality. Trends Immunol 29, 195-201.
Hadinoto V, Shapiro M, Greenough TC, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. 2008. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111: 1420-1427.
Thorley-Lawson DL, Duca KA. 2007. Pathogens cooperate lymphomagenesis. Nat Med 13: 906-907.
Sun CC, Thorley-Lawson D. 2007. Plasma cell-specific transcription factor XBP-1s binds to and transactivates Epstein-Barr virus BZLF1 promoter. J Virol 81: 13566-13577.
Souza TA, Stollar BD, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. 2007. Influence of EBV on the peripheral blood memory B cell compartment. J Immunol 179: 3153-3160.
Duca KA, Shiprio M, Delgado-Eckert E, Hadinoto V, Jarrah AS, Laubenbacher R, Lee K, Luzuriaga K, Polys NF, Thorley-Lawson D. 2007. A vitrual look at Epstein-Barr virus infection: Biological interpretation. Plos Pathog 3: 1388-1400.
Castiglione F, Duca K, Jarrah A, Laubenbacher R, Hochberg D, Thorley-Lawson D. 2007. Simulating Epstein-Barr virus infection with C-ImmSim. Bioinformatics 23: 1371-1377.
Pegtel DM, Subramanian A, Merritt D, Tsai CH, Sheen TS, Golub TR, Thorley-Lawson DA. 2007. IFN-α-stimulated genes and Epstein-Barr virus gene expression distinguish WHO type II and III nasopharyngeal carcinomas. Cancer Res 67: 474-481.